Search

everythinglearnresearchcommunity

for

Search:↓

Only anti-androgenic drugs likely halt AGA progression.

Triangular temporal alopecia can occur in adults and should be correctly identified to prevent misdiagnosis.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Epigenetic and metabolic changes affect stem cell function and aging in skin.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments to slow it but no cure.

Alopecia treatments are improving, but future therapies need to target underlying causes for better results.

Alopecia treatments are improving, but future therapies need to target underlying causes for better results.

New treatments for male pattern hair loss look promising, but established treatments are still the main option.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

GPC1 is important for hair growth by helping blood vessels form around hair follicles.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Current and new treatments for hair loss include topical minoxidil and oral finasteride, but results vary and new options are being explored.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Minoxidil and finasteride are key treatments for hair loss.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

DHT stops hair regrowth in mice, similar to human hair loss.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Minoxidil stimulates hair growth by increasing hair thickness and prolonging growth phase.

Morroniside may help hair grow and stay in its growth phase by affecting certain cell signals.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Combining light therapy and microneedling shows promise for treating female hair loss.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Use a frontal forelock pattern to manage advanced hair loss.